Practical Geriatric Oncology

Arti Hurria, MD, is a geriatrician and oncologist who focuses on the care of older patients with cancer. She completed a geriatric fellowship in the Harvard Geriatric Fellowship Program, followed by a hematology-oncology fellowship at the Memorial Sloan–Kettering Cancer Center (MSKCC). She subsequently joined the faculty at MSKCC, where she served as Co-Principal Investigator on the institutional NIH P20 grant 'Development of an Aging and Cancer Center at MSKCC'. In the fall of 2006, Dr Hurria joined the City of Hope as Director of the Cancer and Aging Research Program. Dr Hurria is a cadre member of the Cancer and Leukemia Group B, Cancer in the Elderly Committee, and is a recipient of the Paul Beeson Career Development Award in Aging Research (K23 AG026749-01) and the American Society of Clinical Oncology's Association of Specialty Professors' Junior Development Award in Geriatric Oncology. She serves on the editorial board of the Journal of the National Cancer Institute, the Journal of Clinical Oncology and Oncologist.

Harvey Jay Cohen, MD, is a geriatrician and oncologist who serves in several professional roles at Duke University Medical Center, including Walter Kempner Professor and Chair for the Department of Medicine, Director of the Center for the Study of Aging and Human Development, and Principal Investigator of the Duke Claude Pepper Older Americans Independence Center. In addition, he also chairs the Cancer in the Elderly Committee for Cancer and Acute Leukemia Group B (CALGB) and co-chairs the Task Force on Cancer and Aging for the American Association for Cancer Research. He is a member of the International Association of Gerontology Governing Board and a past president of the American Geriatrics Society, the Gerontological Society of America and the International Society of Geriatric Oncology. Dr Cohen is on the Editorial Board of the Journal of Gerontology: Medical Sciences, the International Editorial Board of Geriatrics and Gerontology International and the Editorial Advisory Board of both the American Journal of Geriatric Pharmacotherapy and Research News. He has received the Joseph T. Freeman Award and the Kent Award from the Gerontological Society of America, the Jahnigen Memorial Award from the American Geriatrics Society, the Paul Calabresi Award from the International Society of Geriatric Oncology and the Clinically-Based Research Mentoring Award from Duke University.